Vaginal Microbiome Profiling Using Blocking Primers for BV Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing and monitoring bacterial vaginosis (BV) are inaccurate and fail to detect subdominant species, leading to high recurrence rates and unclear etiology due to complex vaginal microbiota.
Innovation Solution
The use of custom primers and blocking primers, such as peptide nucleic acid (PNA) clamping, to selectively amplify and identify non-dominant bacterial species by blocking amplification of dominant species, allowing for a more comprehensive analysis of vaginal microbiomes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional amplification methods are used to detect bacterial species in vaginal microbiota, then dominant species can be detected, but subdominant species remain undetected due to overwhelming amplification of dominant species
Solution Approach 1:
The patent extracts and removes the amplification signal of dominant species from the total amplification signal through subtraction analysis. By comparing amplification curves with and without blocking primers, the method isolates the subdominant species signal that would otherwise be masked by dominant species amplification.
Solution Approach 2:
Blocking primers serve as intermediary molecules that specifically bind to dominant species DNA and prevent their amplification. This allows the PCR reaction to selectively amplify subdominant species without the interference of dominant species, enabling their detection and quantification.
2Measurement precision
If blocking primers are used to amplify non-dominant species, then detection of subdominant species is enhanced, but the method complexity increases
Solution Approach 1:
The blocking primers are designed with universal binding sites that can target multiple dominant species simultaneously while allowing all subdominant species to be amplified. This multi-functional approach enables comprehensive detection of diverse bacterial communities without requiring separate assays for each species.
Solution Approach 2:
The patent segments the amplification process into two distinct phases: total amplification (without blocking) and blocked amplification (with blocking primers). This segmentation allows independent optimization of each phase and simplifies data analysis through straightforward subtraction of amplification signals.
3Productivity
If standard PCR amplification is performed on complex vaginal microbiota, then amplification is rapid, but the accuracy of species identification is reduced due to dominance of few species
Solution Approach 1:
Blocking primers act as intermediary agents that selectively inhibit the amplification of dominant species during the PCR process. This mediation allows the reaction to proceed at normal speed while accurately representing the true species composition by preventing over-amplification of dominant species.
Solution Approach 2:
The patent changes the amplification parameters by introducing blocking primers that alter the kinetics of DNA amplification. This parameter change selectively reduces the amplification efficiency of dominant species while maintaining normal amplification of subdominant species, achieving accurate species composition data without sacrificing productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances the detection of diverse but less dominant species, providing early indicators of BV and predicting recurrence, thereby improving diagnosis and treatment efficacy.
Implementation Method 1
The use of custom primers and blocking primers, such as peptide nucleic acid (PNA) clamping, to selectively amplify and identify non-dominant bacterial species by blocking amplification of dominant species
Data Source
AI summary
Systems and methods to assess the health of various microbiomes and to identity species therein are disclosed. Described assessments and identifications can inform treatment decisions if a microbiome is determined to have a less than optimal balance of bacterial species within it; the presence of one or more negative species; and/or the absence of one or more positive species.